Bacil Pharma Ltd - Stock Valuation and Financial Performance

BSE: 524516 | NSE: | Pharmaceuticals & Drugs | Small Cap

Bacil Pharma Share Price

44.32 -0.90 -1.99%
as on 21-Nov'24 16:59

DeciZen - make an informed investing decision on Bacil Pharma

M-Cap below 100cr DeciZen not available

Bacil Pharma stock performance -

mw4me loader
P/E Ratio (SA):
69.00
Market Cap:
26.6 Cr.
52-wk low:
4.7
52-wk high:
50

Is Bacil Pharma Ltd an attractive stock to invest in?

1. Is Bacil Pharma Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Bacil Pharma Ltd is a below average quality company.

2. Is Bacil Pharma Ltd undervalued or overvalued?

The key valuation ratios of Bacil Pharma Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Bacil Pharma Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Bacil Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Bacil Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bacil Pharma Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % -0.5%-1.1%-0%-83%-16.2%-17.2%-15.1%-273.3%-8.5%-4.8%-
Value Creation
Index
-1.0-1.1-1.0-6.9-2.2-2.2-2.1-20.5-1.6-1.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00000000000
Sales YoY Gr.-NANANANANANANANANA-
Adj EPS -0.1-0.1-0.1-2.3-0.4-0.2-0.2-2.1-0.2-0.20.7
YoY Gr.-NANANANANANANANANA-
BVPS (₹) 9.98.69.82.72.21.31.310.811.8
Adj Net
Profit
0-0.1-0.1-1.3-0.2-0.1-0.1-1.2-0.1-0.10
Cash Flow from Ops. 0.30.101.4-0.3-0.4-0.4-4-0.20-
Debt/CF from Ops. 0.64.5-66.60-0.3-0.5-0.4-0-0.1-33.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANANA
Adj EPS NANANANA
BVPS-22.7%-14.6%-8.5%25.6%
Share Price 25.3% 85.8% 99.2% 651.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
-0.5-1-1.2-30.8-11.1-8.1-10.1-94-11.8-11.248.4
Op. Profit
Mgn %
0000000000NAN
Net Profit
Mgn %
0000000000INF
Debt to
Equity
00.10.100.10.10.1000.10
Working Cap
Days
00000000000
Cash Conv.
Cycle
00000000000

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 48.40%

Sales growth has been subdued in last 3 years 0.00%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Bacil Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) 0.7 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 1.8 -
Reserves (₹ Cr.) -5 -
P/BV 25.91 -
PE 69.00 -
From the Market
52 Week Low / High (₹) 4.68 / 50.02
All Time Low / High (₹) 0.80 / 50.02
Market Cap (₹ Cr.) 26.6
Equity (₹ Cr.) 5.9
Face Value (₹) 10
Industry PE 43

Management X-Ray of Bacil Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Bacil Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales0000000000
Operating Expenses 0.110.130.170.300.430.440.303.910.210.19
Manufacturing Costs000.010.030.0100000
Material Costs0000000000
Employee Cost 0.030.040.080.130.080.090.050.060.090.10
Other Costs 0.080.090.090.140.340.340.253.850.120.09
Operating Profit -0.11-0.13-0.17-0.30-0.43-0.44-0.30-3.91-0.21-0.19
Operating Profit Margin (%) ----------
Other Income 0.080.060.170.270.090.140.070.060.110.13
Interest 0000.0300.010000
Depreciation 0000.010.010.010000
Exceptional Items 000-3.69000000
Profit Before Tax -0.03-0.070-3.75-0.34-0.32-0.24-3.86-0.10-0.06
Tax 0000000000
Profit After Tax -0.03-0.070-3.75-0.34-0.32-0.24-3.86-0.10-0.06
PAT Margin (%) ----------
Adjusted EPS (₹)-0.1-0.10.0-6.4-0.6-0.5-0.4-6.6-0.2-0.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 6.476.406.432.241.911.391.391.221.101.21
Share Capital 6.536.536.536.536.536.536.536.536.536.53
Reserves -0.06-0.13-0.09-4.29-4.62-5.14-5.14-5.30-5.43-5.31
Minority Interest0000000000
Debt0.140.270.3100.100.170.180.030.020.10
Long Term Debt0000000000
Short Term Debt0.140.270.3100.100.170.180.030.020.10
Trade Payables0.010000.040.040.010.0100
Others Liabilities 0.010.020.022.412.392.322.40-0.11-0.11-0.04
Total Liabilities 6.626.696.774.654.433.913.981.161.011.27

Fixed Assets

Gross Block0.015.265.952.562.562.562.560.060.060.06
Accumulated Depreciation0.010.010.010.020.030.040.040.050.050.05
Net Fixed Assets0.015.255.942.532.532.522.510.010.010.01
CWIP 5.88000000000
Investments 0.510.510.541.150.960.430.370.310.430.61
Inventories0000000000
Trade Receivables0000.01000000
Cash Equivalents 0.020.020.040.270.090.040.100.230.030.04
Others Assets0.210.910.250.680.860.920.990.610.550.61
Total Assets 6.626.696.774.654.433.913.981.161.011.27

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 0.260.0601.44-0.30-0.38-0.40-4.01-0.150
PBT -0.03-0.070-3.75-0.34-0.32-0.24-3.86-0.10-0.06
Adjustment 0003.43-0.09-0.13-0.14-0.05-0.03-0.03
Changes in Working Capital 0.290.13-0.011.760.130.07-0.02-0.1-0.020.08
Tax Paid 0000000000
Cash Flow From Investing Activity -0.33-0.050.02-1.200.280.390.533.81-0.120.08
Capex 0-5.240-0.30000.39000
Net Investments -0.2600.02-0.930.190.2503.75-0.150.05
Others -0.075.1900.030.090.140.140.060.030.03
Cash Flow From Financing Activity 0000-0.16-0.06-0.070.330.06-0.06
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0000-0.16-0.06-0.070.330.06-0.06
Net Cash Flow -0.070.010.020.23-0.18-0.050.060.13-0.200.01
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)-0.54-1.23-0.04-101.39-23.83-31.16-31.82-575.48-19.42-11.36
ROCE (%)-0.48-1.06-0.03-83.02-16.18-17.2-15.05-273.27-8.45-4.79
Asset Turnover Ratio0000000000
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days0000000000
Inventory Days0000000000
Payable Days0000000000

Bacil Pharma Ltd Stock News

Bacil Pharma Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Bacil Pharma on 21-Nov-2024 16:59 is ₹44.32.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Bacil Pharma stood at ₹26.63.
The latest P/E ratio of Bacil Pharma as of 21-Nov-2024 16:59 is 69.00.
The latest P/B ratio of Bacil Pharma as of 21-Nov-2024 16:59 is 25.91.
The 52-week high of Bacil Pharma is ₹50.02 and the 52-week low is ₹4.68.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bacil Pharma is ₹0.00 ( Cr.) .

About Bacil Pharma Ltd

Bacil Pharma was incorporated in the year 1987. Its plant is located at Lote-Parshuraram, an industrial area about 250 kilometer from Mumbai city.

Business profile:

The company manufactures bulk pharmaceutical/ chemical manufacturing heavy, medium and fine chemicals. The Lote-Parshuraram plant also has manufacture facility for herbal extract and drug intermediates.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.